Effect of Oral Silymarin Administration on Prevention of Radiotherapy Induced Mucositis: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial

A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies

(2016) Angelo A. Izzo et al.   PHYTOTHERAPY RESEARCH

Protective effects of silymarin on epirubicin-induced mucosal barrier injury of the gastrointestinal tract

(2015) Alciona Sasu et al.   DRUG AND CHEMICAL TOXICOLOGY

Effect of Silymarin Administration on Cisplatin Nephrotoxicity: Report from A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial

(2015) Foroud Shahbazi et al.   PHYTOTHERAPY RESEARCH

Examination of the Patient with Head and Neck Cancer

(2015) Rachel Georgopoulos et al.   Surgical Oncology Clinics of North America

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

(2014) Rajesh V. Lalla et al.   CANCER

Modulatory effect of silymarin on inflammatory mediators in experimentally induced benign prostatic hyperplasia: emphasis on PTEN, HIF-1α, and NF-κB

(2014) Reem T. Atawia et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Critical role for IL-1β in DNA damage-induced mucositis

(2014) Naama Kanarek et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers

(2013) Anil K. Chaturvedi et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of Silymarin (Milk Thistle) on Liver Disease in Patients With Chronic Hepatitis C Unsuccessfully Treated With Interferon Therapy

(2012) Michael W. Fried   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

5-Fluorouracil Induced Intestinal Mucositis via Nuclear Factor-κB Activation by Transcriptomic Analysis and In Vivo Bioluminescence Imaging

(2012) Chung-Ta Chang et al.   PLoS One

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Silymarin in the Prevention and Treatment of Liver Diseases and Primary Liver Cancer

(2011) Janos Feher et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Topical Use of a Silymarin-Based Preparation to Prevent Radiodermatitis

(2011) Martina Becker-Schiebe et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Silymarin suppress CD4+ T cell activation and proliferation: Effects on NF-κB activity and IL-2 production

(2010) Marjan Gharagozloo et al.   PHARMACOLOGICAL RESEARCH

Effect of silymarin administration on TNF-α serum concentration in peritoneal dialysis patients

(2010) Fatemeh Nazemian et al.   PHYTOTHERAPY RESEARCH

Medication Adherence

(2009) P. Michael Ho et al.   CIRCULATION

Drug–drug interactions of silymarin on the perspective of pharmacokinetics

(2008) Jhy-Wen Wu et al.   JOURNAL OF ETHNOPHARMACOLOGY

Strategies for Managing Radiation-Induced Mucositis in Head and Neck Cancer

(2008) David I. Rosenthal et al.   SEMINARS IN RADIATION ONCOLOGY